Read More Analyst Ratings Where Zscaler Stands With Analysts By Benzinga Insights November 2, 3:16 PM Within the last quarter, Zscaler (NASDAQ:ZS) has observed the following analyst ratings: ZS
Read More Biotech General News PDS Biotech Announces Acceptance Of Abstract On Combination Of PDS0301 With Docetaxel In Metastatic Prostate Cancer For Oral Presentation By The National Cancer Institute At Cytokines 2023 By Benzinga Newsdesk July 17, 8:05 AM PDS Biotechnology Corporation (NASDAQ:PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company's proprietary PDSB
Read More Analyst Ratings Analyst Ratings For Fiserv By Benzinga Insights December 22, 10:00 AM Throughout the last three months, 11 analysts have evaluated Fiserv (NYSE:FI), offering a diverse set of opinions from… FI
Read More Guidance News SHEL Updates 4Q23 Outlook, Now Sees Integrated Gas Production Of 880-920 Thousand boe/d (Prior 870-930); Upstream Production Of 1,830-1,930 Thousand boe/d. (Prior 1,750-1,950); Marketing Sales Volumes Of 2,350-2,750 Thousand b/d (Prior 2,250-2,750) By Benzinga Newsdesk January 8, 3:32 AM Volume Data Q3'23 Adjusted Q4'23 QPR Outlook Q4'23 Updated Outlook Integrated Gas Production (kboe/d) 900 870 - SHEL